Lauren Smith, APRN
Adult Health · Saint Louis, MONPI 1427675800
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,956 of the $5,808 with a category attached, or 85.3%. It is spread thinly across 46 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $25.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$731
- Johnson & Johnson$505
- Merck$498
- Daiichi Sankyo Inc.$446
- Novartis$382
- Gilead$373
- plus $3K from 40 others
What the payments were for
- Food & beverage$4,95685%
- Education$85215%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,808 in reported general payments places this provider in the 90th percentile of 555 adult health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 124 | $9,921 |
| Letrozole | 71 | $1,846 |
| Prochlorperazine Maleate | 123 | $1,126 |
| Raloxifene Hcl | 23 | $975 |
| Pantoprazole Sodium | 161 | $922 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 58 | $737 |
| LoperamideLoperamide Hcl | 31 | $650 |
| Dexamethasone | 37 | $642 |
| Acyclovir | 18 | $304 |
| Famotidine | 28 | $263 |
| Ondansetron OdtOndansetron | 15 | $224 |
| Alendronate Sodium | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other adult health in Saint Louis
- Stephanie VogelSaint Louis$115K
- Shannon TuckerSaint Louis$93K
- Laurencia KlipfelSaint Louis$79K
- Maria WallsSaint Louis$69K
- Jennifer SpeiserSaint Louis$27K
- Michele NobsSaint Louis$15K
- Lisa Koester WiedemannSaint Louis$14K
- Erin DoserSaint Louis$13K
- Marcee StegemeierSaint Louis$12K
- Heather PophamSaint Louis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.